Bio-Rad Laboratories Competitors

Bio-Rad Laboratories (CNSX:BIO) and (THCX.V) (CVE:THCX) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

Analyst Recommendations

This is a summary of current ratings and price targets for Bio-Rad Laboratories and (THCX.V), as reported by MarketBeat.

Earnings and Valuation

This table compares Bio-Rad Laboratories and (THCX.V)'s revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Bio-Rad Laboratories and (THCX.V)'s net margins, return on equity and return on assets.

Bio-Rad Laboratories (CNSX:BIO) and 31444 (CNSX:GLH) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability.

Analyst Recommendations

This is a breakdown of current ratings for Bio-Rad Laboratories and 31444, as provided by MarketBeat.

Earnings and Valuation

This table compares Bio-Rad Laboratories and 31444's revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Bio-Rad Laboratories and 31444's net margins, return on equity and return on assets.

Bio-Rad Laboratories (CNSX:BIO) and 438280 (CNSX:ACG) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Valuation and Earnings

This table compares Bio-Rad Laboratories and 438280's top-line revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a summary of current recommendations and price targets for Bio-Rad Laboratories and 438280, as provided by MarketBeat.com.

Profitability

This table compares Bio-Rad Laboratories and 438280's net margins, return on equity and return on assets.

815446 (CNSX:HC) and Bio-Rad Laboratories (CNSX:BIO) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for 815446 and Bio-Rad Laboratories, as reported by MarketBeat.com.

Profitability

This table compares 815446 and Bio-Rad Laboratories' net margins, return on equity and return on assets.

Valuation and Earnings

This table compares 815446 and Bio-Rad Laboratories' gross revenue, earnings per share and valuation.

Bio-Rad Laboratories (CNSX:BIO) and Blueberries Medical (CNSX:BBM) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of current ratings for Bio-Rad Laboratories and Blueberries Medical, as reported by MarketBeat.com.

Profitability

This table compares Bio-Rad Laboratories and Blueberries Medical's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Bio-Rad Laboratories and Blueberries Medical's revenue, earnings per share (EPS) and valuation.

Bio-Rad Laboratories (CNSX:BIO) and Cannara Biotech (CNSX:LOVE) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of current ratings for Bio-Rad Laboratories and Cannara Biotech, as reported by MarketBeat.com.

Profitability

This table compares Bio-Rad Laboratories and Cannara Biotech's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Bio-Rad Laboratories and Cannara Biotech's revenue, earnings per share (EPS) and valuation.